集中和护理解决方案(CPS), headquartered in Rotkreuz, Switzerland, is the largest business area of Roche Diagnostics and the world’s leading supplier of in vitro diagnostic solutions, instrument systems, tests, and services that empower healthcare professionals to optimize care and improve outcomes for their patients.
满足诊断测试的不断变化
增加可预测性和可靠性措施，有助于减少对患者的风险和医疗保健系统的成本是罗氏诊断致力于满足诊断测试不断变化的需求的承诺的最前沿。创新是我们业务战略的基础，我们不断努力创建综合解决方案，以实现跨越各种医疗保健设置的迅速和临床验证的决策。
加强医疗价值
CPS has a strong focus on the clinical chemistry and immunoassay business, which offers high medical value tests for screening, diagnosis, prediction, and monitoring of disease, across a wide field of indications such as oncology, hematology, women’s health, infectious disease, endocrinology, cardiology and personalised healthcare. In addition, CPS offers point-of-care testing products to support clinical decision-making in doctors’ offices, emergency rooms and other primary and care settings. Most recently, CPS entered a new era in lab coagulation and hematology diagnostics with an innovative portfolio that support clinicians and labs with integrated and efficient laboratory solutions, which deliver increased medical value.
实现综合核心实验室的愿景
Roche Diagnostics继续通过整合和整合在其他学科中的更广泛的平台来扩展集成的核心实验室，该学科包括分子诊断和护理点，以及在凝血，血液学和尿液中的测试。这种集成的核心实验室意味着每个组件都设计成一个，扩大诊断功能的效率，范围和质量，使测试更简单，更具成本效益和更有洞察力。
通过现在进行下一步，CPS继续履行提供高质量，集成和简化诊断测试的承诺，以加强对医疗保健的访问，并对患者的生活产生差异。